CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $90,000 | +1185.7% | 20,194 | +1631.9% | 0.00% | – |
Q2 2021 | $7,000 | -12.5% | 1,166 | -0.1% | 0.00% | – |
Q1 2021 | $8,000 | +166.7% | 1,167 | +122.7% | 0.00% | – |
Q4 2020 | $3,000 | -40.0% | 524 | -34.0% | 0.00% | – |
Q3 2020 | $5,000 | -16.7% | 794 | -2.6% | 0.00% | – |
Q2 2020 | $6,000 | 0.0% | 815 | -5.8% | 0.00% | – |
Q1 2020 | $6,000 | -99.7% | 865 | -99.6% | 0.00% | -100.0% |
Q4 2019 | $2,060,000 | +119.1% | 197,572 | -17.4% | 0.01% | +150.0% |
Q3 2019 | $940,000 | +285.2% | 239,095 | +2780.7% | 0.00% | +100.0% |
Q3 2018 | $244,000 | -35.3% | 8,300 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $377,000 | -13.9% | 8,300 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $438,000 | -59.7% | 8,300 | -48.1% | 0.00% | -66.7% |
Q4 2017 | $1,088,000 | +32.0% | 16,000 | +60.0% | 0.00% | +50.0% |
Q3 2017 | $824,000 | -70.0% | 10,000 | -65.9% | 0.00% | -75.0% |
Q2 2017 | $2,746,000 | +86.9% | 29,330 | +27.2% | 0.01% | +100.0% |
Q1 2017 | $1,469,000 | +129.2% | 23,065 | +59.9% | 0.00% | +100.0% |
Q4 2016 | $641,000 | +290.9% | 14,423 | +20.6% | 0.00% | – |
Q2 2016 | $164,000 | -91.1% | 11,957 | -40.2% | 0.00% | -100.0% |
Q3 2015 | $1,839,000 | +4.6% | 20,000 | 0.0% | 0.01% | +20.0% |
Q2 2015 | $1,758,000 | +58.0% | 20,000 | +33.3% | 0.01% | +66.7% |
Q1 2015 | $1,113,000 | +98.8% | 15,000 | +50.0% | 0.00% | +50.0% |
Q4 2014 | $560,000 | -17.6% | 10,000 | -33.3% | 0.00% | 0.0% |
Q3 2014 | $680,000 | -45.2% | 15,000 | -50.0% | 0.00% | -50.0% |
Q2 2014 | $1,242,000 | -10.3% | 30,000 | +50.0% | 0.00% | -20.0% |
Q1 2014 | $1,385,000 | +13.9% | 20,000 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $1,216,000 | +81.5% | 20,000 | +100.0% | 0.01% | +66.7% |
Q2 2013 | $670,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |